About: Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 09 March 2016

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2016 (ast) наукова стаття, опублікована в березні 2016 (uk) مقالة علمية نشرت في 09 مارس 2016 (ar) scientific article published on 09 March 2016 (en)
publication date	wds:Q37452679-BF3A39A0-0641-4D8B-98A5-5D9ECBEE1879
publication date	2016-03-09 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37452679-8625957D-5149-4C87-8DBD-CE3F58E9E64F
language of work or name	English
exact match	wds:Q37452679-D9858BC4-5C47-42A8-A176-955AFE64E4A2
exact match	https://scigraph.springernature.com/pub.10.1007/s00330-016-4268-8
cites work	wds:Q37452679-18B5FE14-DEDC-4C24-89BB-122AE7AF8BC4 wds:Q37452679-23776525-98AF-4BEC-8C36-DCA82FE68FEC wds:Q37452679-2B03DF17-3908-45C7-B465-818D623BF917 wds:Q37452679-38BBBBF7-F649-43D1-8AD1-45F303B454CB wds:Q37452679-3CBF5179-9D61-4CFB-ADB3-41DCFD50D928 wds:Q37452679-3FBC435D-5BF3-4320-88B3-1ECF9412F136 wds:Q37452679-41B6FEF1-6C0A-45E1-9ACF-9446581ED8D8 wds:Q37452679-46E03D5A-473E-4045-8656-3B8A5A2F4001 wds:Q37452679-51708566-D2CC-4EC6-B133-FC877338674F wds:Q37452679-56D8B310-D046-4500-A50B-09E33B2A48DB wds:Q37452679-62B9998E-88E8-43AD-B1E6-915EAD8BF3EB wds:Q37452679-728324DA-A6EE-4EBC-9A0D-C6AEA4513EE3 wds:Q37452679-77A948D6-A2EB-4F35-ACB7-3EE3518EA669 wds:Q37452679-7B1B1C7F-C629-4B82-A187-6009FDD0A0FC wds:Q37452679-816EBF27-AEFF-44DB-AE5F-CCFEC4BE47E7 wds:Q37452679-875A5B78-B8E2-4BB1-9D58-011CEC0045DD wds:Q37452679-96A6CA13-05CB-4B11-8680-21587D3EC327 wds:Q37452679-973FB14D-9B1D-4B89-8268-55F367F02545 wds:Q37452679-97A72FDD-5DFD-4F99-8D5E-37DAFD26D346 wds:Q37452679-9B6CBE9F-51C1-4A17-9BE3-7ABF7DDCE1AD wds:Q37452679-9C9BCD06-2562-4746-86CE-CB8E75799D66 wds:Q37452679-B4291B37-3DB9-4473-86ED-80DFCF2B08B0 wds:Q37452679-B8FD2F09-D6E0-488B-8AD9-305EB16E22CA wds:Q37452679-C90151B4-CF29-46B5-B1AD-9FAC061B896F wds:Q37452679-FB83279C-D4C1-432E-BA29-3EBFE61C073B
cites work	Perfusion MRI: the five most frequently asked technical questions Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship Incidence of immediate gadolinium contrast media reactions. Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths Prevalence of acute adverse reactions to gadobutrol--a highly concentrated macrocyclic gadolinium chelate: review of 14,299 patients from observational trials Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity Clinical Safety and Diagnostic Value of the Gadolinium Chelate Gadoterate Meglumine (Gd-DOTA) Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging Safety of gadobutrol, a new generation of contrast agents: experience from clinical trials and postmarketing surveillance Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers Clinical safety of gadopentetate dimeglumine Comments on the case report reported by Elmholdt et al. Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol NSF after Gadovist exposure: a case report and hypothesis of NSF development Safety of gadoterate meglumine (Gd-DOTA) as a contrast agent for magnetic resonance imaging: results of a post-marketing surveillance study in Japan Tolerability and diagnostic value of gadoteric acid in the general population and in patients with risk factors: results in more than 84,000 patients Gadobutrol: a review of its use for contrast-enhanced magnetic resonance imaging in adults and children Pharmacokinetics and Safety of Macrocyclic Gadobutrol in Children Aged Younger Than 2 Years Including Term Newborns in Comparison to Older Populations Gadobutrol for contrast-enhanced magnetic resonance imaging in elderly patients: review of the safety profile from clinical trial, post-marketing surveillance, and pharmacovigilance data. Contrast material for abdominal dynamic contrast-enhanced 3D MR angiography with parallel imaging: intraindividual equimolar comparison of a macrocyclic 1.0 M gadolinium chelate and a linear ionic 0.5 M gadolinium chelate Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients
author name string	wds:Q37452679-31F2AC62-DB6D-4B86-B1CE-4D6B8516C20A wds:Q37452679-3923B398-52A9-46D6-BFB1-2F279C10877C wds:Q37452679-4F9BE0FE-8AA4-49CC-90D4-829AB2C02A29 wds:Q37452679-508E18DD-1DFD-4964-AA7D-8F243291A090 wds:Q37452679-5EE53615-8ADD-4215-AB5D-5A6725E4D28D wds:Q37452679-7900EED9-8EDC-45B5-86D7-8565A63AA773 wds:Q37452679-8288833A-1512-41AB-8BE4-71410D133442 wds:Q37452679-8347F423-1FE5-47D0-80BA-CE143EE4BFE6 wds:Q37452679-A953AD16-B218-470C-A103-5A1779F66001 wds:Q37452679-AC9327F3-66EC-4E47-BE2E-55E6BAB4C815 wds:Q37452679-D27A5610-CDE4-4891-9C99-610F11C0A463 wds:Q37452679-E28C8C4A-57AC-4F1F-A501-865029D46AF3
author name string	Jin Wang Guo-Shu Huang Haiping Wang Woong Yoon In Ho Lee Benqiang Yang Chang-Hee Lee Jiing-Feng Lirng Hae Giu Lee Sung Won Youn Petra Palkowitsch GARDIAN study group
rdfs:label	Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study. (en) Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study. (nl) Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study. (ast)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software